Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Sorafenib market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Sorafenibmarket, defines the market attractiveness level of Sorafenib market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Sorafenib industry, describes the types of Sorafenib market, the applications of major players and the market size, and deeply analyzes the current situation of the global Sorafenib market and the development prospects and opportunities of Sorafenib industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Sorafenib market in Chapter 13.
By Player:
Bayer
Cipla
Mylan
Natco Pharma
By Type:
Patented Drugs
Generic Drugs
By End-User:
Kidney Cancer
Liver Cancer
Thyroid Cancer
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Sorafenib Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Sorafenib Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Sorafenib Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Sorafenib Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Sorafenib Market Analysis and Outlook to 2022
-
7.1 Global Sorafenib Consumption (2017-2022)
-
7.2 United States Sorafenib Consumption (2017-2022)
-
7.3 Europe Sorafenib Consumption (2017-2022)
-
7.4 China Sorafenib Consumption (2017-2022)
-
7.5 Japan Sorafenib Consumption (2017-2022)
-
7.6 India Sorafenib Consumption (2017-2022)
-
7.7 South Korea Sorafenib Consumption (2017-2022)
8 Region and Country-wise Sorafenib Market Analysis and Outlook to 2028
-
8.1 Global Sorafenib Consumption Forecast (2022-2028)
-
8.2 United States Sorafenib Consumption Forecast (2022-2028)
-
8.3 Europe Sorafenib Consumption Forecast (2022-2028)
-
8.4 China Sorafenib Consumption Forecast (2022-2028)
-
8.5 Japan Sorafenib Consumption Forecast (2022-2028)
-
8.6 India Sorafenib Consumption Forecast (2022-2028)
-
8.7 South Korea Sorafenib Consumption Forecast (2022-2028)
9 Global Sorafenib Market Outlook by Types and Applications to 2022
-
9.1 Global Sorafenib Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Patented Drugs Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Generic Drugs Consumption and Growth Rate (2017-2022)
-
9.2 Global Sorafenib Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Kidney Cancer Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Liver Cancer Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Thyroid Cancer Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Other Consumption and Growth Rate (2017-2022)
10 Global Sorafenib Market Outlook by Types and Applications to 2028
-
10.1 Global Sorafenib Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Patented Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Generic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Sorafenib Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Kidney Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Liver Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Thyroid Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Sorafenib Import and Export Analysis (Top 5 Countries)
-
11.1 Global Sorafenib Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Sorafenib Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Sorafenib Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Sorafenib Market Competitive Analysis
-
14.1 Bayer
-
14.1.1 Bayer Company Details
-
14.1.2 Bayer Sorafenib Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Bayer Sorafenib Product and Service
-
14.2 Cipla
-
14.2.1 Cipla Company Details
-
14.2.2 Cipla Sorafenib Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Cipla Sorafenib Product and Service
-
14.3 Mylan
-
14.3.1 Mylan Company Details
-
14.3.2 Mylan Sorafenib Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Mylan Sorafenib Product and Service
-
14.4 Natco Pharma
-
14.4.1 Natco Pharma Company Details
-
14.4.2 Natco Pharma Sorafenib Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Natco Pharma Sorafenib Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Sorafenib
-
Figure Sorafenib Picture
-
Table Global Sorafenib Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Sorafenib Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Sorafenib Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Sorafenib Consumption by Country (2017-2022)
-
Figure United States Sorafenib Consumption and Growth Rate (2017-2022)
-
Table Europe Sorafenib Consumption and Growth Rate (2017-2022)
-
Figure China Sorafenib Consumption and Growth Rate (2017-2022)
-
Figure Japan Sorafenib Consumption and Growth Rate (2017-2022)
-
Figure India Sorafenib Consumption and Growth Rate (2017-2022)
-
Figure South Korea Sorafenib Consumption and Growth Rate (2017-2022)
-
Figure Global Sorafenib Consumption Forecast by Country (2022-2028)
-
Figure United States Sorafenib Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Sorafenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Sorafenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Sorafenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Sorafenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Sorafenib Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Patented Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Generic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Kidney Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Liver Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Thyroid Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Patented Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Generic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Kidney Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Liver Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Thyroid Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Sorafenib Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Sorafenib Export by Region (Top 5 Countries) (2017-2028)
-
Table Bayer (Foundation Year, Company Profile and etc.)
-
Table Bayer Sorafenib Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Sorafenib Product and Service
-
Table Cipla (Foundation Year, Company Profile and etc.)
-
Table Cipla Sorafenib Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cipla Sorafenib Product and Service
-
Table Mylan (Foundation Year, Company Profile and etc.)
-
Table Mylan Sorafenib Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mylan Sorafenib Product and Service
-
Table Natco Pharma (Foundation Year, Company Profile and etc.)
-
Table Natco Pharma Sorafenib Sales, Price, Value and Gross Profit (2017-2022)
-
Table Natco Pharma Sorafenib Product and Service
-
